NewsBite

Dimerix Limited

ASX Announcements

Application for quotation of securities - DXB

Appendix 2A (Application for Quotation of Securities)

  • Sep 17, 2024
  • 6 pages

Market Sensitive

ACTION3 Trial Recruitment and Multiregion Trial Site Update

Progress Report

  • Sep 16, 2024
  • 4 pages

Application for quotation of securities - DXB

Appendix 2A (Application for Quotation of Securities)

  • Sep 13, 2024
  • 6 pages

Market Sensitive

First Paediatric Site Activated and Trial Update

Progress Report

  • Sep 12, 2024
  • 4 pages

Application for quotation of securities - DXB

Appendix 2A (Application for Quotation of Securities)

  • Sep 11, 2024
  • 6 pages

View all DXB announcements

February

The S&P/ASX 200 closed 87.2 points higher, or 1.2 per cent, to 7297.70, the largest single-day gain since mid-July.

Why analysts love these eight medtech stocks

The sector that straddles healthcare and tech has professionals searching for companies that could be tomorrow’s big winners after Pro Medicus.

  • Tom Richardson

June 2020

Drug discovery company Dimerix launched a capital raising on Thursday.

Dimerix seeks funds to prepare for COVID-19 related global study

Drug discovery tearaway Dimerix – which is trading up more than 200 per cent in the past six months – is making a trip to equity capital markets. 

  • Sarah Thompson, Anthony Macdonald and Tim Boyd

July 2014

Eight stocks to watch

We name some recently listed stocks that analysts The Australian Financial Review spoke to suggested are worth a closer look.

  • Updated
  • Tony Featherstone

Original URL: https://www.afr.com/company/dxb-hf